Literature DB >> 8287391

Recent cardiovascular drugs from Chinese medicinal plants.

M C Sutter1, Y X Wang.   

Abstract

This paper describes the pharmacology of some recent cardiovascular drugs derived from plants used in Chinese traditional medicine. The groups of compounds discussed are benzylisoquinolines (several), tetrahydropyrazine (also called ligustrazine), rhynchophylline and hirsutine, ginkgolides and other PAF inhibitors, coumarins, and ginsenosides, plus a miscellaneous group; approximately 30 substances in all. The plant sources and the pharmacology are indicated for the drugs in each group. By far the most studied compounds are the benzylisoquinolines, especially tetrandrine. The types of pharmacological activity recently described for cardiovascular drugs from plants include calcium antagonism, adrenoceptor antagonism, antagonism of platelet activating factor (PAF), and the ability to act as antioxidants. Hundreds of chemicals have been isolated and identified as constituents of thousands of plants but the basic and clinical pharmacology is known for only a handful of these drugs. Much more research is needed, especially with regard to the pharmacology, both basic and clinical, of the pure chemicals derived from plants.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8287391     DOI: 10.1093/cvr/27.11.1891

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  10 in total

1.  Ligustrazine-induced endothelium-dependent relaxation in pulmonary arteries via an NO-mediated and exogenous L-arginine-dependent mechanism.

Authors:  W Peng; D Hucks; R M Priest; Y M Kan; J P Ward
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 2.  Monitoring the safety of herbal medicines.

Authors:  T Y Chan
Journal:  Drug Saf       Date:  1997-10       Impact factor: 5.606

3.  Protective action of tetramethylpyrazine phosphate against dilated cardiomyopathy in cTnT(R141W) transgenic mice.

Authors:  Hai-ping Zhao; Dan Lü; Wei Zhang; Li Zhang; Shu-mei Wang; Chun-mei Ma; Chuan Qin; Lian-feng Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-02-15       Impact factor: 6.150

4.  Endothelium-dependent vascular relaxation induced by Eucommia ulmoides Oliv. bark extract is mediated by NO and EDHF in small vessels.

Authors:  Chiu-Yin Kwan; Wen-Bo Zhang; Takeshi Deyama; Sansei Nishibe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-13       Impact factor: 3.000

5.  Endothelium-Dependent Relaxation Effect of Apocynum venetum Leaf Extract via Src/PI3K/Akt Signalling Pathway.

Authors:  Yeh Siang Lau; Wei Chih Ling; Dharmani Murugan; Chiu Yin Kwan; Mohd Rais Mustafa
Journal:  Nutrients       Date:  2015-06-30       Impact factor: 5.717

6.  Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates.

Authors:  Zhe Zhang; Jie Yan; Kaijin Xu; Zhongkang Ji; Lanjuan Li
Journal:  BMC Infect Dis       Date:  2015-03-25       Impact factor: 3.090

7.  Rhynchophylline Ameliorates Endothelial Dysfunction via Src-PI3K/Akt-eNOS Cascade in the Cultured Intrarenal Arteries of Spontaneous Hypertensive Rats.

Authors:  Hui-Feng Hao; Li-Mei Liu; Chun-Shui Pan; Chuan-She Wang; Yuan-Sheng Gao; Jing-Yu Fan; Jing-Yan Han
Journal:  Front Physiol       Date:  2017-11-15       Impact factor: 4.566

Review 8.  Advances in adjunct therapy against tuberculosis: Deciphering the emerging role of phytochemicals.

Authors:  Samreen Fatima; Anjna Kumari; Ved Prakash Dwivedi
Journal:  MedComm (2020)       Date:  2021-08-05

9.  Mediation of Endogenous beta-endorphin by Tetrandrine to Lower Plasma Glucose in Streptozotocin-induced Diabetic Rats.

Authors:  Jen-Hao Hsu; Yang-Chang Wu; Shorong-Shii Liou; I -Min Liu; Lee-Wen Huang; Juei-Tang Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2004-09-01       Impact factor: 2.629

10.  The predictive utility of the plant phylogeny in identifying sources of cardiovascular drugs.

Authors:  Emily Guzman; Jeanmaire Molina
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.